主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
WALD
#3054
Waldencast plc Class A Ordinary Share
1.6
9
0.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
0.00%
每月变动
+4.97%
6个月变化
+3.05%
年变化
-45.83%
前一天收盘价
1.6
9
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
交易量
41
市场
股票
技术
WALD
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
34.5 M
86.46 M
101.23 M
112.03 M
—
Valuation ratios
Enterprise value
—
3.15 B
4.22 B
1.53 B
—
Price to earnings ratio
—
-3.8
-11.3
-10.31
—
Price to sales ratio
—
—
4.68
1.6
—
Price to cash flow ratio
—
21.08
34.26
49.82
—
Price to book ratio
—
0.12
1.63
0.66
—
Enterprise value to EBITDA ratio
—
—
-212.61
1 082.27
—
Profitability ratios
Return on assets %
-0.04
-0.06
0.09
0.04
0.29
Return on equity %
0.26
-0.09
0.12
0.06
0.33
Return on invested capital %
—
-44.2
29.55
23.92
—
Gross margin %
—
—
64.9
70.01
—
Operating margin %
—
—
37.56
21.39
—
EBITDA margin %
—
—
-9.1
0.52
—
Net margin %
—
—
41.25
15.5
—
Liquidity ratios
Quick ratio
—
0.51
0.82
0.66
—
Current ratio
4.64
1.26
1.71
1.35
5.02
Inventory turnover
—
1.01
1.39
1.51
—
Asset turnover
—
—
0.2
0.27
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.15
0.15
0.14
0.44
Long term debt to total equity ratio
-0.03
0.25
0.24
0.21
0.67
Per share metrics
Operating cash flow per share
0.04
0
0.33
0.08
4.95
EBIT per share
—
—
-0.9
-0.54
—
EBITDA per share
—
—
-0.22
0.01
—
Total debt per share
—
—
—
—
—
Cash per share
-0.08
1.09
0.23
0.14
0.43
Net current asset value per share
-0.09
11.38
1.18
0.95
3.13
Tangible book value per share
2.86
-41.82
-3.21
-1.77
-6.85
Working capital per share
-0.07
2.32
0.49
0.24
0.97
Book value per share
2.86
79.9
6.85
6.06
22.31
新闻
Obagi Medical选择DermFx作为透明质酸项目合作伙伴
Obagi Medical names DermFx as partner for hyaluronic acid program
Obagi Medical与Next Health合作开展填充剂评估计划
Obagi Medical partners with Next Health for filler evaluation program
Alpha Aesthetics Partners加入Obagi的ALOHA透明质酸填充剂项目
Alpha Aesthetics Partners joins Obagi’s ALOHA program for HA filler
Waldencast公司宣布年度股东大会日期并公布董事会变动
Waldencast schedules annual meeting and announces board changes
Waldencast AcquisitionQ3每股收益及营收逊于预期
Waldencast Acquisition earnings missed by $0.03, revenue fell short of estimates
Canaccord Genuity下调Waldencast股票目标价,原因是销售疲软
Canaccord Genuity lowers Waldencast stock price target on weak sales